{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T13:30:55Z","timestamp":1682602255834},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.clinthera.2008.04.008","type":"journal-article","created":{"date-parts":[[2008,5,21]],"date-time":"2008-05-21T19:11:16Z","timestamp":1211397076000},"page":"633-640","source":"Crossref","is-referenced-by-count":11,"title":["Bioequivalence and pharmacokinetic evaluation of two branded formulations of aceclofenac 100 mg: a single-dose, randomized, open-label, two-period crossover comparison in healthy Korean adult volunteers"],"prefix":"10.1016","volume":"30","author":[{"given":"Si-Youn","family":"Rhim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Hee","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoo-Sin","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie M.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju-Seop","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2008.04.008_bib1_1","unstructured":"Guidance for Industry: Bioavailability and Bioequivalence Studies for Orally Administered Drug Products-General Considerations [US Food and Drug Administration (FDA) Web site]."},{"key":"10.1016\/j.clinthera.2008.04.008_bib2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1185\/03007999509110491","article-title":"A multi-centre, double-blind comparative study of the efficacy and safety of aceclofenac and diclofenac in the treatment of rheumatoid arthritis","volume":"13","author":"Pasero","year":"1995","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2008.04.008_bib3","series-title":"The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals.","year":"2001"},{"key":"10.1016\/j.clinthera.2008.04.008_bib4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0014-2999(97)89179-0","article-title":"Aceclofenac blocks prostaglandin E2 production following its intracellular conversion into cyclooxygenase inhibitors","volume":"329","author":"Yamazaki","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.clinthera.2008.04.008_bib5","series-title":"Martindale: The Extra Pharmacopoeia.","first-page":"67","year":"2005"},{"key":"10.1016\/j.clinthera.2008.04.008_bib6","series-title":"British National Formulary (BNF)","year":"1998"},{"key":"10.1016\/j.clinthera.2008.04.008_bib7","first-page":"453","article-title":"Efficacy and tolerability of aceclofenac in the treatment of gonalgia: Controlled double-blind study vs diclofenac","volume":"42","author":"Torri","year":"1987","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/j.clinthera.2008.04.008_bib8","first-page":"175","article-title":"Efficacy and tolerability of aceclofenac versus ketoprofen in the treatment of rheumatoid arthritis","volume":"51","author":"Giorgianni","year":"1992","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/j.clinthera.2008.04.008_bib9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2165\/00003495-199652010-00008","article-title":"Aceclofenac. A review of its pharmacodynamic properties and therapeutic potential in the treatment of rheumatic disorders and in pain management","volume":"52","author":"Brogden","year":"1996","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2008.04.008_bib10","first-page":"605","article-title":"Dose-analgesic response study and aceclofenac plasma levels in humans","volume":"47","author":"Honorato","year":"1990","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/j.clinthera.2008.04.008_bib11_1","unstructured":"The European Agency for the Evaluation of Medicinal Products, Human Medicines Evaluation Unit, International Conference on Harmonisation. Guideline for Good Clinical Practice [EMEA Web site]."},{"key":"10.1016\/j.clinthera.2008.04.008_bib12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/bdd.388","article-title":"Bioequivalence evaluation of two brands of aceclofenac 100 mg tablets (Aceclofar and Bristaflam) in healthy human volunteers","volume":"25","author":"Najib","year":"2004","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.clinthera.2008.04.008_bib13","first-page":"586","article-title":"Determination and validation of ketoprofen, pantoprazole and valsartan together in human plasma by high performance liquid chromatography","volume":"61","author":"Ko\u00e7yigit-Kaymak\u00e7oglu","year":"2006","journal-title":"Pharmazie"},{"key":"10.1016\/j.clinthera.2008.04.008_bib14","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/bmc.243","article-title":"Simultaneous determination of aceclofenac and three of its metabolites in human plasma by high-performance liquid chromatography","volume":"17","author":"Hinz","year":"2003","journal-title":"Biomed Chromatogr"},{"key":"10.1016\/j.clinthera.2008.04.008_bib15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3109\/03602538608998295","article-title":"PKCALC: A BASIC interactive computer program for statistical and pharmacokinetic analysis of data","volume":"17","author":"Shumaker","year":"1986","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.clinthera.2008.04.008_bib16","unstructured":"FDA Guidance for Industry: Bioavailability and Bioequivalence Studies for Orally Administered Drug Products. Rockville, Md: Office of Generic Drugs, Division of Bioequivalence, US Food and Drug Administration; 2003."},{"key":"10.1016\/j.clinthera.2008.04.008_bib17","series-title":"Design and Analysis of Bioavailability and Bioequivalence Studies.","year":"1992"},{"key":"10.1016\/j.clinthera.2008.04.008_bib18","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1080\/03639040600608805","article-title":"Evaluation of bioequivalence of two formulations containing 100 milligrams of aceclofenac","volume":"32","author":"Gowda","year":"2006","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.clinthera.2008.04.008_bib19","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S1130-6343(06)73982-4","article-title":"Clinical pharmacogenomics for CYP2C8 and CYP2C9: General concepts and application to the use of NSAIDs [in Spanish]","volume":"30","author":"Mart\u00ednez","year":"2006","journal-title":"Farm Hosp"},{"key":"10.1016\/j.clinthera.2008.04.008_bib20","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2146\/ajhp050490","article-title":"Identifying drugs needing pharmacogenetic monitoring in a Korean hospital","volume":"64","author":"Kim","year":"2007","journal-title":"Am J Health Syst Pharm"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291808001471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291808001471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,28]],"date-time":"2018-12-28T12:53:01Z","timestamp":1546001581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291808001471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0149291808001471"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2008.04.008","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}